Houston nonprofit utilizes art to connect medical professionals to patients

In good hands

Doctors are people too — some are even artists. This Houston organization is shining a light on Houston's multifaceted physicians. Courtesy of Arts of Healing

Imagine your doctor holding a paintbrush rather than a stethoscope. The Arts of Healing is working to connect patients to their medical professionals in a new way, encouraging a more personal connection that extends beyond the exam room.

Established in 2017 by Lori and Isaac Raijman, The Arts of Healing Foundation is a Houston-based nonprofit organization that unites physicians from the major hospitals throughout the Texas Medical Center to showcase their unique artistic talents and fundraise for local organizations. Over the past three years, the organization has raised $188,000 for charity.

Lori Raijman, founder, worked as a public school teacher for 24 years, introducing art as a voice and vehicle for her students.

"After my teaching career, I started managing my husband's art business, and he is a physician who paints," Raijman tells InnovationMap. "People would come to his office and talk to him about art, their first encounter with him was different because of the connection through the art."

The Arts of Healing hosts an annual art show where physicians exhibit their work, from painting and photography to music. The 2019 show will take place on Friday, November 8, at the Post Oak Hotel and will benefit The Sunshine Kids Foundation, an organization dedicated to supporting children who are fighting cancer.

The Arts of Healing is also planning events outside of the annual art show where physicians can spend time with the children supported by The Sunshine Kids Foundation. During these events, medical professionals will bring in art supplies and musical instruments to interact with the children.

"It's a different level of giving back in sharing the love you have for creating through an experience," says Raijman.

Past beneficiaries include Lung Force (2018) and Pancreatic Cancer (2017).

Raijman tells InnovationMap that her first art show was in 2008 at Hotel Zaza with an attendance of some 300 people. "Years passed and I was trying to figure out how to have physicians art rotate through the hospitals," said Raijman. "Some hospitals do show photography of their physicians in the call, but there wasn't an exhibit of art anywhere."

In 2017, Issac Raijman's art was noticed by a friend who worked with River Oaks District that offered to display the art inside the stores.

"It was like a lightbulb just went off," Raijman tells InnovationMap.

She then moved forward with gathering a group of physicians to showcase their art at the retail stores and raise money for charity. Some two dozen physicians participated in the first exhibition and around 2,000 people attended.

"You see the physicians willing to show this vulnerability that we don't normally see and as a patient that is refreshing," says Raijman. She explains that she feels patients usually feel vulnerable when dealing with medical professionals, sharing their most personal information.

The Arts of Healing website states that studies show art supports creativity and practice in medicine, making better physicians; it also enables medical professionals to better connect, empathize with, and support their patients.

"It also unifies the doctors of the Texas Medical Center," says Raijman. "When you think about the Texas Medical Center and the gold mine of talent there and it's not been harnessed together in this way before, that's a unique factor."

Raijman is also planning an event that will take place next year for women in the medical field, bringing together medical professionals from a variety or practices and specializations.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

View All Listings